North America generic drugs market is estimated to grow at a CAGR of nearly 7.2% during the forecast period. Significant initiatives by regulatory authorities to stimulate generic drug approvals are supporting to drive market growth. For instance, in October 2007, the US FDA introduced the Generic Initiative for Value and Efficiency (GIVE). As an initiative, GIVE […]
